or Try an Advanced Search...

    Tumor Necrosis Stocks List

    Symbol Grade Name % Change
    AMGN A Amgen Inc. 11.82
    CKPT F Checkpoint Therapeutics, Inc. 6.76
    View As Page of Charts
    Related Industries: Biotechnology Drug Manufacturers - Major
    Related Stock Lists: Epidermal Growth Factor Receptor Medicine Necrosis Tumor Necrosis Factor Antibodies Biotechnology Blood Cells Bone Bone Disease Cancer Care Cancer Immunotherapy Checkpoint Inhibitor Chemotherapy Clinic Dialysis Dow Jones Component Drugs Growth Factors Healthcare Providers Hematology

    Related ETFs - A few ETFs which own one or more of the above listed Tumor Necrosis stocks.

    Symbol Grade Name Weight
    BBH B Market Vectors Biotech ETF 15.08
    IBB C iShares Nasdaq Biotechnology Index Fund 8.68
    IBBQ C Invesco Nasdaq Biotechnology ETF 8.56
    BIS D ProShares UltraShort Nasdaq Biotechnology 8.14
    BIB C ProShares Ultra Nasdaq Biotechnology 6.29
    View all Tumor Necrosis ETFs...
    Compare ETFs
    Compare BBH to IBB Compare IBB to BIS Compare IBB to IBBQ

        Tumor Necrosis Stocks Recent News

        Date Stock Title
        May 3 AMGN Why Amgen Stock Zoomed Nearly 12% Higher Today
        May 3 AMGN Amgen's peek at its GLP-1 drug trial results heightens competition in obesity market
        May 3 AMGN Analyst unveils Amgen stock price target after weight-loss drug data
        May 3 AMGN Amgen's Q1 Earnings: Solid All Court Progress, Major Weight Loss Catalyst Pending
        May 3 AMGN Interest rate cuts could switch ‘from stroll to a sprint’ after US jobs surprise
        May 3 AMGN William Blair, Barclays upgrade Amgen following GLP-1 drug update
        May 3 AMGN Top Midday Stories: Apple's Dividend, Buybacks Announcements; Amgen Obesity Drug Trial Results; Exxon Completes Pioneer Acquisition
        May 3 AMGN US STOCKS-Wall St rallies after soft jobs data allays rate jitters
        May 3 AMGN Amgen (AMGN) Q1 Earnings Top, Stock Up on Obesity Drug Update
        May 3 AMGN Weight-loss drug competition heats up. Is Wegovy in trouble?
        May 3 AMGN Amgen Inc. (NASDAQ:AMGN) Q1 2024 Earnings Call Transcript
        May 3 AMGN Dow Jones Soars 400 Points As Amgen, Apple Surge; Nvidia Jumps Again, Tempts New Buyers
        May 3 AMGN US STOCKS-Wall St gains after soft jobs data allays rate jitters
        May 3 AMGN Amgen stock rallies 13% on GLP-1 weight-loss drug update
        May 3 AMGN Amgen Knocks Novo Nordisk's Ozempic Stock Rally
        May 3 AMGN Amgen Posts Upbeat Results, Joins OneSpan, Paylocity Holding, MercadoLibre And Other Big Stocks Moving Higher On Friday
        May 3 AMGN Amgen surges over confidence in early obesity drug results
        May 3 AMGN These Two Stocks Are Driving the Dow Friday
        May 3 AMGN Stocks to Watch Friday: Apple, Amgen, Coinbase, Block
        May 3 AMGN Amgen upgraded, Peloton downgraded: Wall Street's top analyst calls
        Related Industries: Biotechnology Drug Manufacturers - Major
        Related Stock Lists: Epidermal Growth Factor Receptor Medicine Necrosis Tumor Necrosis Factor Antibodies Biotechnology Blood Cells Bone Bone Disease Cancer Care Cancer Immunotherapy Checkpoint Inhibitor Chemotherapy Clinic Dialysis Dow Jones Component Drugs Growth Factors Healthcare Providers Hematology
        Tumor Necrosis

        Tumor Necrosis is a type of cell death that occurs when cells are exposed to certain stimuli, such as radiation, chemotherapy, or certain drugs. It is a form of programmed cell death that is triggered by the body's own immune system in response to the presence of a tumor. Tumor Necrosis can be beneficial, as it can help to reduce the size of a tumor and prevent it from spreading.

        Browse All Tags